Ngenla Injection, Solution
Product Images NDC 0069-0505
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 48 technical images submitted to the FDA as part of the official labeling for Ngenla (NDC 0069-0505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Somatrogon 02)
Logo (Somatrogon 03)
Image (Somatrogon 05)
Image (Somatrogon 06)
Step 2 (Somatrogon 07)
Choose and clean your injection site. For abdominal sites, keep at least 2 inches (5 cm) away from the belly button. For rear upper arms, only caregivers can administer the injection. For front upper thighs, choose this site for injection. For buttocks, only caregivers can administer the injection.*
Step 3 (Somatrogon 08)
Step 4 (Somatrogon 09)
Step 5 (Somatrogon 10)
Step 6 (Somatrogon 11)
Image (Somatrogon 12)
Image (Somatrogon 13)
Image (Somatrogon 14)
Image (Somatrogon 15)
Step 7 (Somatrogon 16)
Example A (Somatrogon 17)
Example B (Somatrogon 18)
Step 8 (Somatrogon 19)
Step 9 (Somatrogon 20)
Step 10 (Somatrogon 21)
Step 11 (Somatrogon 22)
Step 12 (Somatrogon 23)
Step 13 (Somatrogon 24)
Logo (Somatrogon 25)
Image (Somatrogon 26)
Image (Somatrogon 27)
Step 2 (Somatrogon 28)
Step 3 (Somatrogon 29)
Step 4 (Somatrogon 30)
Step 5 (Somatrogon 31)
Step 6 (Somatrogon 32)
Image (Somatrogon 33)
Image (Somatrogon 34)
Image (Somatrogon 35)
Image (Somatrogon 36)
Step 7 (Somatrogon 37)
Example A (Somatrogon 38)
Example B (Somatrogon 39)
Step 8 (Somatrogon 40)
Step 9 (Somatrogon 41)
Step 10 (Somatrogon 42)
Step 11 (Somatrogon 43)
Step 12 (Somatrogon 44)
Step 13 (Somatrogon 45)
Principal Display Panel (24 mg Cartridge Label)
Manufactured by Pfizer Ireland Pharmaceuticals in Ringaskiddy, Cork, Ireland. U.S. License No. 2060. This is a medication that is administered through subcutaneous injection. It is a single-patient-use product that should be discarded after 28 days of first use. The medication is stored refrigerated. The specific dosage and concentration are not available due to the unclear text.*
Principal Display Panel (24 mg Cartridge Carton)
Principal Display Panel (60 mg Cartridge Label)
Principal Display Panel (60 mg Cartridge Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.